- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The Great Debate at “Melanoma Bridge”, Napoli, December 2nd, 2017 ; volume:16 ; number:1 ; day:17 ; month:4 ; year:2018 ; pages:1-12 ; date:12.2018
Journal of translational medicine ; 16, Heft 1 (17.4.2018), 1-12, 12.2018
- Creator
-
Ascierto, Paolo A.
- Contributor
-
Caracò, Corrado
Gershenwald, Jeffrey E.
Hamid, Omid
Ross, Merrick
Sullivan, Ryan J.
Puzanov, Igor
SpringerLink (Online service)
- DOI
-
10.1186/s12967-018-1477-8
- URN
-
urn:nbn:de:101:1-2018062122530381661307
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ascierto, Paolo A.
- Caracò, Corrado
- Gershenwald, Jeffrey E.
- Hamid, Omid
- Ross, Merrick
- Sullivan, Ryan J.
- Puzanov, Igor
- SpringerLink (Online service)
Other Objects (12)
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Melanoma: A model for testing new agents in combination therapies
What have we learned from cancer immunotherapy in the last 3 years?
Combination therapy: the next opportunity and challenge of medicine
The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021
World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016
The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Melanoma: A model for testing new agents in combination therapies
What have we learned from cancer immunotherapy in the last 3 years?
Combination therapy: the next opportunity and challenge of medicine
The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021
World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016
The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Melanoma: A model for testing new agents in combination therapies
What have we learned from cancer immunotherapy in the last 3 years?
Combination therapy: the next opportunity and challenge of medicine
The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021
World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016
The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application